Inovio Pharmaceuticals Stock (NASDAQ: INO) stock price, news, charts, stock research, profile.
Open | $13.000 |
Close | - |
Volume / Avg. | 510.618K / 532.280K |
Day Range | 13.000 - 14.690 |
52 Wk Range | 3.888 - 13.320 |
Market Cap | $331.913M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 79 |
Short Interest | 7.52% |
Days to Cover | 3.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inovio Pharmaceuticals (NASDAQ: INO) through any online brokerage.
Other companies in Inovio Pharmaceuticals’s space includes: Humacyte (NASDAQ:HUMA), Adverum Biotechnologies (NASDAQ:ADVM), Precigen (NASDAQ:PGEN), Gritstone Bio (NASDAQ:GRTS) and Mesoblast (NASDAQ:MESO).
The latest price target for Inovio Pharmaceuticals (NASDAQ: INO) was reported by Oppenheimer on Friday, March 8, 2024. The analyst firm set a price target for 40.00 expecting INO to rise to within 12 months (a possible 181.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $14.2023 last updated Today at March 28, 2024 at 12:01 PM EDT.
There are no upcoming dividends for Inovio Pharmaceuticals.
Inovio Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Inovio Pharmaceuticals.
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.